How should clinical evidence be used in device evaluation?

How should clinical evidence be used in device evaluation?

• A. Use only vendor claims.
• B. Gather clinical data, perform literature reviews, conduct post-market surveillance, and integrate evidence into benefit-risk assessment.
• C. Only rely on lab data.
• D. Skip post-market surveillance.

Answer: (B)

Using clinical evidence in device evaluation means pulling together different kinds of evidence to form a complete picture of how a device performs in real-world clinical use. The best approach is to gather clinical data from studies and registries, review the existing literature, monitor post-market surveillance for safety and effectiveness signals, and integrate all of this into a structured benefit–risk assessment. This ensures the evaluation captures how the device works across diverse patients and real-world settings, includes long-term and rare adverse events, and informs decisions about labeling, indications, and ongoing monitoring. Relying on vendor claims can introduce bias, and relying only on lab data misses how the device behaves in actual clinical use. Skipping post-market surveillance misses important safety and performance information that only emerges after broad deployment. By combining multiple evidence sources, you get a balanced, evidence-based view of whether the device’s benefits outweigh its risks.

Using clinical evidence in device evaluation means pulling together different kinds of evidence to form a complete picture of how a device performs in real-world clinical use. The best approach is to gather clinical data from studies and registries, review the existing literature, monitor post-market surveillance for safety and effectiveness signals, and integrate all of this into a structured benefit–risk assessment. This ensures the evaluation captures how the device works across diverse patients and real-world settings, includes long-term and rare adverse events, and informs decisions about labeling, indications, and ongoing monitoring.

Relying on vendor claims can introduce bias, and relying only on lab data misses how the device behaves in actual clinical use. Skipping post-market surveillance misses important safety and performance information that only emerges after broad deployment. By combining multiple evidence sources, you get a balanced, evidence-based view of whether the device’s benefits outweigh its risks.